Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian A Gordon

Showing results (81-90 of 262) with videos related to

Pageof 27
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 5, 2018
Cerebrospinal fluid biomarkers measured by Elecsys assays compared to amyloid imagingSuzanne E Schindler, Julia D Gray, Brian A Gordon, et al.
Neuroimage|July 31, 2017
AV-1451 PET imaging of tau pathology in preclinical Alzheimer disease: Defining a summary measureShruti Mishra, Brian A Gordon, Yi Su, et al.
JAMA Neurology|January 8, 2019
Assessment of Racial Disparities in Biomarkers for Alzheimer DiseaseJohn C Morris, Suzanne E Schindler, Lena M McCue, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 20, 2023
A practitioner's guide to geospatial analysis in a neuroimaging contextJulie K Wisch, Ganesh M Babulal, Kalen Petersen, et al.
Neurobiology of Aging|October 30, 2016
Clinical, imaging, pathological, and biochemical characterization of a novel presenilin 1 mutation (N135Y) causing Alzheimer's diseaseMarissa Natelson Love, David G Clark, J Nicholas Cochran, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 22, 2018
Cross-sectional and longitudinal atrophy is preferentially associated with tau rather than amyloid β positron emission tomography pathologyBrian A Gordon, Austin McCullough, Shruti Mishra, et al.
Neurology|July 1, 2018
Loss of white matter integrity reflects tau accumulation in Alzheimer disease defined regionsJeremy F Strain, Robert X Smith, Helen Beaumont, et al.
Neurology|August 3, 2019
High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosisSuzanne E Schindler, James G Bollinger, Vitaliy Ovod, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersNicole S McKay, Stephanie Doering, David A Hoagey, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 23, 2024
Predicting continuous amyloid PET values with CSF tau phosphorylation occupanciesJulie K Wisch, Brian A Gordon, Nicolas R Barthélemy, et al.
Pageof 27

Showing results (81-90 of 262) with videos related to

Sort By:
Pageof 27
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 5, 2018
Cerebrospinal fluid biomarkers measured by Elecsys assays compared to amyloid imagingSuzanne E Schindler, Julia D Gray, Brian A Gordon, et al.
Neuroimage|July 31, 2017
AV-1451 PET imaging of tau pathology in preclinical Alzheimer disease: Defining a summary measureShruti Mishra, Brian A Gordon, Yi Su, et al.
JAMA Neurology|January 8, 2019
Assessment of Racial Disparities in Biomarkers for Alzheimer DiseaseJohn C Morris, Suzanne E Schindler, Lena M McCue, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 20, 2023
A practitioner's guide to geospatial analysis in a neuroimaging contextJulie K Wisch, Ganesh M Babulal, Kalen Petersen, et al.
Neurobiology of Aging|October 30, 2016
Clinical, imaging, pathological, and biochemical characterization of a novel presenilin 1 mutation (N135Y) causing Alzheimer's diseaseMarissa Natelson Love, David G Clark, J Nicholas Cochran, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 22, 2018
Cross-sectional and longitudinal atrophy is preferentially associated with tau rather than amyloid β positron emission tomography pathologyBrian A Gordon, Austin McCullough, Shruti Mishra, et al.
Neurology|July 1, 2018
Loss of white matter integrity reflects tau accumulation in Alzheimer disease defined regionsJeremy F Strain, Robert X Smith, Helen Beaumont, et al.
Neurology|August 3, 2019
High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosisSuzanne E Schindler, James G Bollinger, Vitaliy Ovod, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersNicole S McKay, Stephanie Doering, David A Hoagey, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 23, 2024
Predicting continuous amyloid PET values with CSF tau phosphorylation occupanciesJulie K Wisch, Brian A Gordon, Nicolas R Barthélemy, et al.
Pageof 27